Argenx
ARGX
#447
Rank
NZ$90.60 B
Marketcap
NZ$1,455
Share price
0.47%
Change (1 day)
30.43%
Change (1 year)
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.

ESG Reports

Thumbnail Argenx
 ESG Report 2022

ESG Report 2022

Language: English

View ESG Report
Thumbnail Argenx
 ESG Report 2021

ESG Report 2021

Language: English

View ESG Report